AI Article Synopsis
- The study investigated the effects of intermittent fasting (IF) on patients with non-alcoholic fatty liver disease (NAFLD) and prediabetes.
- The research involved 95 patients, split into two groups: one with obesity and the other with prediabetes, both having a BMI between 30.0 kg/m² and 34.5 kg/m².
- Results showed that IF significantly improved body measurements and metabolic markers after 6 and 12 months, with additional benefits when metformin was used following the fasting period.
Article Abstract
Objective: The aim: To study intermittent fasting (IF) treatment in patients with non-alcoholic fatty liver disease (NAFLD) and prediabetes.
Patients And Methods: Materials and methods: Patients with NAFLD (n=95) were examined. The patients were divided into 2 groups: Group 1 - NAFLD with obesity, Group 2 - NAFLD and prediabetes. All patients in both groups had Body mass index (BMI) within the 2nd degree of obesity range (30.0 kg/m2 to 34.5 kg/m2).
Results: Results: The effect of IF on anthropometric parameters, carbohydrate and lipid levels in patients with NAFLD with obesity and NAFLD with prediabetes, 6 and 12 months after treatment is shown.
Conclusion: Conclusions: Intermittent fasting has a statistically significant effect on anthropometric parameters in NAFLD with obesity and NAFLD with prediabetes. Metformin administration after intermittent fasting in 12 months showed a statistically significant improvement in lipid and carbohydrate profiles.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.36740/WLek202303109 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!